Satya Easwaran to be replaced with Badri Srinivasan.
The amount will be used to fund the payout for the voluntary retirement scheme (VRA), which is likely to cost over Rs 200 crore.
Observations are for Pithampur Unit-2 facility.
License is for manufacturing the generic version of ViiV's HIV drug.
All major sectoral indices are in green.
The company supplies its products to 9 out of top 10 global tyre manufacturers and to all of the top 11 tyre, paint, footwear and cosmetics manufacturers in India
Investment made under PLI scheme.
Nifty Media index down by 2%.
Non-convertible debentures (NCDs) are fixed income securities that is listed with stock exchanges, like BSE and NSE in India.